|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
Q1 FY2014
As of Mar 31, 2014
|
Q4 FY2013
As of Dec 31, 2013
|
Q3 FY2013
As of Sep 30, 2013
|
Q2 FY2013
As of Jun 30, 2013
|
Q1 FY2013
As of Mar 31, 2013
|
Q4 FY2012
As of Dec 31, 2012
|
Q3 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Jun 30, 2012
|
Q1 FY2012
As of Mar 31, 2012
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||||||
| Cash and due from financial institutions | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Securities available-for-sale | ||||||||||||||||||||
| Loans | ||||||||||||||||||||
| Less allowance for loan losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Real estate owned | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Investment in FHLB stock | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Premises and equipment held for sale | ||||||||||||||||||||
| Bank-owned life insurance | ||||||||||||||||||||
| Deferred tax asset, net | ||||||||||||||||||||
| Accrued interest receivable and other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||
| Deposits: | ||||||||||||||||||||
| Non-interest bearing | ||||||||||||||||||||
| Interest bearing | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Deposits held for sale | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Borrowings | ||||||||||||||||||||
| Obligations under capital lease | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Shareholders’ equity: | ||||||||||||||||||||
| Preferred stock, no par value, 2,000,000 shares authorized, none issued and outstanding | ||||||||||||||||||||
| Common shares, 17,500,000 shares authorized, 7,660,492 and 7,588,887 shares issued, and 7,338,092 and 7,281,237 shares outstanding for 2016 and 2015, respectively | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Treasury stock, at cost, 322,400 and 307,650 shares at December 31, 2016 and 2015, respectively | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Deferred stock-based compensation | ||||||||||||||||||||
| Total shareholders’ equity | ||||||||||||||||||||
| Total liabilities and shareholders’ equity | ||||||||||||||||||||
| Common shares outstanding | ||||||||||||||||||||
| Book value per common share | ||||||||||||||||||||
Loading...
